CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: A pilot study

Clinical Transplantation

Volumn 24, Issue 3, 2010, Pages 401-409

  Sund, Fredrik ^a   Lidehäll, Anna Karin ^a   Claesson, Kerstin ^a   Foss, Aksel ^b   Tötterman, Thomas H ^a   Korsgren, Olle ^a   Eriksson, Britt Marie ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

CMV; CMV DNAemia; CMV specific immunity; Renal transplantation; Tetramer

Indexed keywords

GAMMA INTERFERON; VIRUS DNA;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL REGENERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MORBIDITY; MORTALITY; NONHUMAN; PERIPHERAL LYMPHOCYTE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; T LYMPHOCYTE; VIRUS LOAD; CASE CONTROL STUDY; COMPARATIVE STUDY; CYTOMEGALOVIRUS; EPIDEMIOLOGY; GENETICS; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; PROGNOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANTATION IMMUNOLOGY; VIRAL LOAD;

EID: 77954173564     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00976.x     Document Type: Article

References (26)

1. Dharnidharka VR, Caillard S, Agodoa LY, Abbott KC. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation 2006, 81:1662.
2. Sagedal S, Nordal KP, Hartmann A. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002, 2:850.
3. Humar A, Gillingham K, Payne WD, Sutherland D, Matas AJ. Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease. Transplantation 2000, 70:310.
4. Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev 2003, 196:247.
5. Radha R, Jordan S, Puliyanda D. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant 2005, 5:110.
6. Sester U, Gärtner BC, Wilkens H. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 2005, 5:1483.
7. Gerna G, Lilleri D, Fornara C. Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation. Am J Transplant 2006, 6:2356.
8. Bunde T, Kirchner A, Hoffmeister B. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005, 201:1031.
9. Lilleri D, Zelini P, Fornara C, Comolli G, Gerna G. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients. Am J Transplant 2007, 7:1997.
10. Lidehall AK, Sund F, Lundberg T, Eriksson BM, Tötterman TH, Korsgren O. T cell control of primary and latent cytomegalovirus infections in healthy subjects. J Clin Immunol 2005, 25:473.
11. Sylwester AW, Mitchell BL, Edgar JB. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005, 25:473.
12. Hart GD, Paya CV. Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 2001, 11:73.
13. Emery VC. Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation. Rev Med Virol 2001, 11:83.
14. Sagedal S, Hartmann A, Rollag H. The impact of early cytomegalovirus infection and disease in renal transplant recipients. Clin Microbiol Infect 2005, 11:518.
15. Khoury JA, Storch GA, Bohl DL. Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients. Am J Transplant 2006, 6:2134.
16. Mousavi-Jazi M, Scloss L, Wahren B, Brytting M. Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase. J Clin Virol 2003, 26:301.
17. Engstrand M, Tournay C, Peyrat M. Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 2000, 69:2243.
18. Engstrand M, Lidehäll AK, Tötterman TH, Herrman B, Eriksson BM, Korsgren O. Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. Clin Exp Immunol 2003, 132:96.
19. Gratama JW, Keeney M, Sutherland DR. Enumeration of CD34+ hematopoetic stem and progenitor cells. Current Protocols in Cytometre 1999, 6.4.1. Robinson JP, Darzynkiewicz Z, Dean PNDressler LGRabinowitch PSStewart CCTanke HJWheeless LL. In, eds, New York, Wiley
20. Kranz B, Vester U, Wingen AM. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection. Pediatr Transplant 2008, 12:474.
21. Gratama JW, van Esser JWJ, Lamers CHJ. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001, 98:1358.
22. Gamadia LE, Rentenaar RJ, Baars PA. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001, 98:754.
23. Gamadia LE, Rentenaar RJ, van Lier RAW, ten Berge IJM. Properties of CD4(+) T cells in human cytomegalovirus infection. Hum Immunol 2004, 65:486.
24. Sester M, Sester U, Gärtner B. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001, 71:1287.
25. Khanolkar A, Fuller MJ, Zajac AJ. CD4 cell-dependent CD8 T cell maturation. J Immunol 2004, 172:2834.
26. Bronke C, Palmer NM, Jansen CA. Dynamics of cytomegalovirus (CMV)-specific T-cells in HIV-1-infected individuals progressing to CMV end-organ disease. J Infect Dis 2005, 191:873.